PerkinElmer Q2 Revenues Up 2 Percent; Discloses Bioo Scientific Acquisition | GenomeWeb

This article has been updated to include a downgrade note from Mizuho Securities.

NEW YORK (GenomeWeb) – PerkinElmer reported after the close of the market on Thursday that its second quarter revenues rose 2 percent year over year thanks to a 4 percent increase in its human health business which offset a 1 percent dip in environmental health revenues.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.